Latest acute leukemia Stories
Interim Data from 33 Evaluable Patients to be Presented at ASH on Saturday SAN DIEGO, Dec. 2, 2014 /PRNewswire/ -- MEI Pharma, Inc.
WHITE PLAINS, N.Y., Dec.
Company expects Induction Response Rate data in Second Quarter of 2015 EWING, N.J., Dec. 1, 2014 /PRNewswire/-- Celator Pharmaceuticals, Inc.
SEATTLE, Dec. 1, 2014 /PRNewswire/ -- CTI BioPharma Corp.
EWING, N.J., Nov. 24, 2014 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
BERGEN, Norway, November 19, 2014 /PRNewswire/ -- BerGenBio AS, an oncology biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has
BERGEN, Norway, November 4, 2014 /PRNewswire/ -- BerGenBio AS ("BerGenBio" or the "Company"), an oncology biopharmaceutical company, today announces that the first patient
- Tosedostat Currently in Phase 2 Development for Patients with AML and MDS - SEATTLE, Oct. 27, 2014 /PRNewswire/ -- CTI BioPharma Corp.
- Preliminary study results show 27 of 30 pediatric and adult patients with relapsed/refractory (r/r) ALL (90%) experienced complete remissions with personalized cell therapy, CTL0191 EAST
University of Pennsylvania and Children's Hospital of Philadelphia Research Team Funded by LLS for More Than 22 Years Report Today in New England Journal of Medicine that 90 Percent of Patients Achieved
- To writhe; struggle or twist about with more or less force; wriggle.
- To scribble, jot.